Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_assertion type Assertion NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_head.
- NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_assertion description "[Compared to controls, a significantly higher percentage of CD16 and CD35+ monocytes from XLA (P = 0.002 and P = 0.007, respectively) were observed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_provenance.
- NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_assertion evidence source_evidence_literature NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_provenance.
- NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_assertion SIO_000772 17900300 NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_provenance.
- NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_assertion wasDerivedFrom befree-2016 NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_provenance.
- NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_assertion wasGeneratedBy ECO_0000203 NP632264.RAFTl4j9yAQmzQsLA6aYf9kArAtSaozokbcxsrgJW-OkQ130_provenance.